全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

粪便钙卫蛋白联合床旁超声在新生儿坏死性小肠结肠炎早期诊断中的临床应用进展
Clinical Application Progress of Fecal Calprotectin Combined with Point-of-Care Ultrasound in the Early Diagnosis of Neonatal Necrotizing Enterocolitis

DOI: 10.12677/jcpm.2025.42252, PP. 851-855

Keywords: 新生儿,坏死性小肠结肠炎,粪便钙卫蛋白,床旁超声,早期诊断
Neonates
, Necrotizing Enterocolitis, Fecal Calprotectin, Point-of-Care Ultrasound, Early Diagnosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

新生儿坏死性小肠结肠炎(NEC)是一种在新生儿中较为严重的消化系统疾病,早期诊断对于提高患者生存率十分重要。虽然NEC在临床上的认识逐渐加深,但由于临床表现多种多样,传统的诊断方法可能存在延误和失准的问题。近年来,由于在炎症反应中表现出的高敏感性和特异性,作为特异性生物标志物的粪便钙卫蛋白(FC)逐渐受到关注。同时,作为能够实时评估新生儿肠道状态的快速无创影像学检查技术,床旁超声(Pocus)为NEC的早期诊断提供了新的可能。本文旨在分析粪便钙卫蛋白和床旁超声在新生儿坏死性小肠结肠炎中的应用进展,探讨这两种方法在提高NEC早期识别能力方面的临床价值及潜力。
Neonatal necrotizing enterocolitis (NEC) is a serious digestive disease in newborns, and early diagnosis is important to improve patient survival. Although NEC is gradually becoming better recognized clinically, traditional diagnostic methods may suffer from delays and inaccuracies due to the variety of clinical presentations. In recent years, fecal calreticulin (FC), as a specific biomarker, has been gaining attention due to its high sensitivity and specificity in inflammatory response. Meanwhile, as a rapid and noninvasive imaging technique capable of real-time assessment of the intestinal status of neonates, point-of-care ultrasound (Pocus) offers new possibilities for the early diagnosis of NEC. The purpose of this article is to analyze the progress of fecal calreticulin and bedside ultrasound in neonatal necrotizing small bowel colitis, and to explore the clinical value and potential of these two methods in improving the early recognition of NEC.

References

[1]  Farghaly, M.A.A., Ali, M.A.M., Ramey, S., Said, W., Abdelkarem, A. and Collin, M. (2023) Characteristics of Fecal Calprotectin as an Early Marker for Suspected Necrotizing Enterocolitis in Newborns Exclusively Fed Maternal Breast Milk: A Case-Control Study. Baylor University Medical Center Proceedings, 37, 43-47.
https://doi.org/10.1080/08998280.2023.2277580
[2]  王娟, 粱宽. 新生儿坏死性小肠结肠炎不良预后的危险因素及其预测价值[J]. 海南医学, 2022, 33(23): 3049-3052.
[3]  Xie, Y.Q., Ren, C.J., Wang, X., Xiang, S.W., Wang, X.X. and Hao, L. (2021) [Role of Fecal Calprotectin in the Diagnosis of Neonatal Necrotizing Enterocolitis: A Meta Analysis]. Chinese Journal of Contemporary Pediatrics, 23, 381-389.
https://pubmed.ncbi.nlm.nih.gov/33840411/
[4]  Maheshwari, A., Suryawanshi, P., Chetan, C., Garegrat, R. and Hazarika, J. (2023) Point-of-Care Ultrasound to Diagnose and Monitor the Course of Necrotizing Enterocolitis. Newborn, 2, 203-213.
https://doi.org/10.5005/jp-journals-11002-0070
[5]  Oulego-Erroz, I., Rodríguez-Fanjul, J., Terroba-Seara, S., Sorribes-Orti, C., Fernandez-Fernández, D., Fuentes-Martínez, S., et al. (2022) Bedside Ultrasound for Early Diagnosis of Necrotizing Enterocolitis: A Pilot Study. American Journal of Perinatology, 41, e630-e640.
https://doi.org/10.1055/a-1925-1797
[6]  彭宜丽. 新生儿坏死性小肠结肠炎的相关临床因素分析[D]: [硕士学位论文]. 广州: 广州医科大学, 2023.
[7]  Liu, S., Liu, Y., Lai, S., Xie, Y., Xiu, W. and Yang, C. (2024) Values of Serum Intestinal Fatty Acid-Binding Protein, Fecal Calprotectin, and Fecal Human β-Defensin 2 for Predicting Necrotizing Enterocolitis. BMC Pediatrics, 24, Article No. 183.
https://doi.org/10.1186/s12887-024-04667-5
[8]  谢艳秋, 任常军, 王雄, 等. 粪便钙卫蛋白对新生儿坏死性小肠结肠炎诊断作用的Meta分析[J]. 中国当代儿科杂志, 2021, 23(4): 381-389.
[9]  Hong, L., Zhang, L., Zhou, Q., Li, S., Han, J., Jiang, S., et al. (2021) Impacts of Enriched Human Milk Cells on Fecal Metabolome and Gut Microbiome of Premature Infants with Stage I Necrotizing Enterocolitis: A Pilot Study. Molecular Nutrition & Food Research, 66, e2100342.
https://doi.org/10.1002/mnfr.202100342
[10]  Bos, V., Crouwel, F., Waaijenberg, P., Bouma, G., Duijvestein, M., Buiter, H.J.C., et al. (2022) Salivary Calprotectin Is Not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases, 31, 283-289.
https://doi.org/10.15403/jgld-4215
[11]  Hu, T., Zhang, Z., Song, F., Zhang, W. and Yang, J. (2023) Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-Analysis. Turkish Journal of Gastroenterology, 34, 892-901.
https://pubmed.ncbi.nlm.nih.gov/37427885/
[12]  Jain, A., Vasnaik, M., Singam, A. and Mudiganti, V.N.K.S. (2024) A Cross-Sectional Study on Bedside Abdominal Ultrasound Findings as a Diagnostic and Prognostic Tool in Dengue Fever in Manipal Hospital, Bengaluru, India. Cureus, 16, e64734.
https://pubmed.ncbi.nlm.nih.gov/39156261/
[13]  Paysal, J., Oris, C., Troin, U., Limeri, P., Allard, J., Tadrent, M., et al. (2023) Influence of Perinatal Factors on Blood Tryptase and Fecal Calprotectin Levels in Newborns. Children, 10, Article 345.
https://doi.org/10.3390/children10020345
[14]  Goold, E., Pearson, L. and Johnson, L.M. (2020) Can Fecal Calprotectin Serve as a Screen for Necrotizing Enterocolitis in Infants? Clinical Biochemistry, 84, 51-54.
https://doi.org/10.1016/j.clinbiochem.2020.06.015
[15]  Chen, G., Lv, X. and Tang, W. (2023) Fecal Calprotectin as a Non-Invasive Marker for the Prediction of Post-Necrotizing Enterocolitis Stricture. Pediatric Surgery International, 39, Article No. 250.
https://doi.org/10.1007/s00383-023-05534-7
[16]  Ng, P.C., Chan, K.Y.Y., Lam, H.S., Wong, R.P.O., Ma, T.P.Y., Sit, T., et al. (2020) A Prospective Cohort Study of Fecal miR-223 and miR-451a as Noninvasive and Specific Biomarkers for Diagnosis of Necrotizing Enterocolitis in Preterm Infants. Neonatology, 117, 555-561.
https://doi.org/10.1159/000511655
[17]  Cui, C., Chen, F.L. and Li, L.Q. (2023) [Recent Research on Machine Learning in the Diagnosis and Treatment of Necrotizing Enterocolitis in Neonates]. Chinese Journal of Contemporary, 25, 767-773.
https://pubmed.ncbi.nlm.nih.gov/37529961/

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133